Janvi Sah

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Combination Therapy

End Stage Renal Disease

Prognostic Factors

Patient Reported Outcomes

Top Venues

Advances in therapy

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Marcus-Alexander Wörns, Danielle Burns, Michael Paskow, Harriet Makin, Jordan Miller, Lucy M Turner, Janvi Sah
Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map. Advances in therapy 41 (9) (2024)
Amanda Teeple, Janvi Sah, Rajesh Mallampati, Christopher Adams, Dexter Waters, Erik Muser
Persistence, Dosing, and Other Treatment Patterns Among Crohn's Disease Patients Initiating Biologics in United States. Crohn's & colitis 360 3 (4) (2021)
Amanda Teeple, Janvi Sah, Rajesh Mallampati, Christopher Adams, Dexter Waters, Erik Muser
Persistence, Dosing, and Other Treatment Patterns Among Crohn's Disease Patients Initiating Biologics in United States. Crohn's & colitis 360 3 (4) (2021)